Want to see IN:KRSNAA full AI Analyst Report?

Krsnaa Diagnostics Limited (KRSNAA) Price & Analysis

1 Followers

KRSNAA Stock Chart & Stats

₹735.10

₹3.75(0.41%)

At close: Jan 08 4:00 PM EST

₹735.10

₹3.75(0.41%)

Day’s Range― - ―

52-Week Range₹502.20 - ₹891.80

Previous CloseN/A

Volume110.72K

Average Volume (3M)12.28K

Market Cap

₹18.22B

Enterprise Value₹19.03B

Total Cash (Recent Filing)₹1.60B

Total Debt (Recent Filing)₹2.86B

Price to Earnings (P/E)18.3

Beta1.09

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.38%

Share Statistics

EPS (TTM)26.14

Shares Outstanding32,438,670

10 Day Avg. Volume19,408

30 Day Avg. Volume12,281

Financial Highlights & Ratios

PEG Ratio0.55

Price to Book (P/B)1.72

Price to Sales (P/S)2.18

P/FCF Ratio-17.89

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)46

Revenue Forecast (FY)₹9.94B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSustained top-line growth from ~4.55B to ~7.73B over 2022–2026 indicates persistent demand for diagnostic services. This revenue momentum supports scale benefits, capacity utilisation and provides a foundation for steady long-term earnings and reinvestment.

Improved Balance-sheet And DeleveragingMeaningful debt reduction and moderate leverage (debt-to-equity ~0.04–0.23 recently) materially improve financial flexibility. A stronger balance sheet lowers refinancing risk, supports capital spending for network expansion and cushions against sector cyclicality.

PPP/outsourcing Business ModelA core PPP/outsourcing model secures contracted volumes and institutional relationships, creating a differentiated route to stable utilization. Long-term government and hospital partnerships drive recurring revenue, predictable site economics and scalable rollouts.

Bears Say

Persistent Negative Free Cash FlowChronic negative free cash flow despite positive operating cash flow suggests heavy capex, working-capital strain or receivable build-up. This reduces internal funding for expansion, increases reliance on external financing and constrains shareholder returns over the medium term.

Volatile Profitability And MarginsMaterial margin swings across years show cost structure and pricing vulnerability. Such volatility undermines predictability of earnings, complicates long-term planning, and raises execution risk for sustaining improved profitability through cycles.

Exposure To Government Receivables And Payment TimingReliance on government contracts and timely payments creates structural cash-flow risk; delayed receivables can amplify working-capital needs, force short-term funding, and impair ability to fund capex or absorb local operational disruptions.

Krsnaa Diagnostics Limited News

Krsnaa Diagnostics Posts Record Profit and Accelerates Retail Expansion in FY2026

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an update. Krsnaa Diagnostics reported its highest-ever consolidated profit after...

1M ago

Krsnaa Diagnostics Releases Investor Presentation on FY2026 Results

An announcement from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) is now available. Krsnaa Diagnostics has released an investor...

1M ago

Krsnaa Diagnostics overhauls board and finance leadership in governance revamp

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics has moved to overhaul its leadership...

3M ago

Krsnaa Diagnostics Shareholders Clear Five-Year Reappointment of Executive Chairman

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an announcement. Krsnaa Diagnostics Limited has secured shareholder approval via...

3M ago

Krsnaa Diagnostics Shareholders Approve Re-Appointment of Executive Chairman

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has issued an update. Krsnaa Diagnostics Limited has secured shareholder approval via...

3M ago

Krsnaa Diagnostics Publishes Postal Ballot Notice for Shareholder E-Voting

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an announcement. Krsnaa Diagnostics Limited has notified stock exchanges that...

4M ago

Krsnaa Diagnostics Extends Tenure of Executive Chairman Rajendra Mutha

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has shared an update. Krsnaa Diagnostics Limited’s board has approved the re-appointment...

4M ago

Krsnaa Diagnostics Reappoints Executive Chairman Rajendra Mutha for Five-Year Term

An announcement from Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) is now available. Krsnaa Diagnostics Limited has approved the...

4M ago

Krsnaa Diagnostics Publishes Q3 FY26 Earnings Call Transcript

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) has provided an update. Krsnaa Diagnostics Limited has released the transcript of...

5M ago

Krsnaa Diagnostics Plans Mumbai Investor Meeting Under SEBI Norms

Krsnaa Diagnostics Limited ( ($IN:KRSNAA) ) just unveiled an announcement. Krsnaa Diagnostics has scheduled a one-on-one physical meeting...

5M ago

KRSNAA FAQ

What was Krsnaa Diagnostics Limited’s price range in the past 12 months?

Krsnaa Diagnostics Limited lowest stock price was ₹502.20 and its highest was ₹891.80 in the past 12 months.

What is Krsnaa Diagnostics Limited’s market cap?

Krsnaa Diagnostics Limited’s market cap is ₹18.22B.

When is Krsnaa Diagnostics Limited’s upcoming earnings report date?

Krsnaa Diagnostics Limited’s upcoming earnings report date is Aug 06, 2026 which is in 32 days.

How were Krsnaa Diagnostics Limited’s earnings last quarter?

Krsnaa Diagnostics Limited released its earnings results on May 25, 2026. The company reported ₹9.655 earnings per share for the quarter, beating the consensus estimate of ₹2.45 by ₹7.205.

Is Krsnaa Diagnostics Limited overvalued?

According to Wall Street analysts Krsnaa Diagnostics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Krsnaa Diagnostics Limited pay dividends?

Krsnaa Diagnostics Limited pays a Annually dividend of ₹2.75 which represents an annual dividend yield of 0.38%. See more information on Krsnaa Diagnostics Limited dividends here

What is Krsnaa Diagnostics Limited’s EPS estimate?

Krsnaa Diagnostics Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Krsnaa Diagnostics Limited have?

Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.

What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?

Krsnaa Diagnostics Limited reported an EPS of ₹9.655 in its last earnings report, beating expectations of ₹2.45. Following the earnings report the stock price went down -1.219%.

Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?

Currently, no hedge funds are holding shares in IN:KRSNAA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Krsnaa Diagnostics Limited

Krsnaa Diagnostics Limited specializes in delivering a comprehensive range of diagnostic solutions. The company utilizes technology to provide services such as radiology, clinical pathology, and tele-radiology to diverse clients, including public and private healthcare facilities, medical colleges, and local community health centers. By December 31, 2020, its extensive network featured 1,801 diagnostic centers distributed across 13 Indian states. Established in 2010, the company maintains its headquarters in Pune, India.